Literature DB >> 12921942

Ribonucleotide reductase: an old target with new potential.

B Douglas Smith1, Judith E Karp.   

Abstract

Mesh：

Substances：

Year:  2003        PMID： 12921942     DOI： 10.1016/s0145-2126(03)00248-0

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  9 in total

1.  Biochemical modulation of aracytidine (Ara-C) effects by GTI-2040, a ribonucleotide reductase inhibitor, in K562 human leukemia cells.

Authors:  Ping Chen; Josephine Aimiuwu; Zhiliang Xie; Xiaohui Wei; Shujun Liu; Rebecca Klisovic; Guido Marcucci; Kenneth K Chan
Journal:  AAPS J       Date:  2010-12-30       Impact factor: 4.009

2.  Understanding the molecular interactions of different radical scavengers with ribonucleotide reductase M2 (hRRM2) domain: opening the gates and gaining access.

Authors:  Arijit Basu; Barij N Sinha
Journal:  J Comput Aided Mol Des       Date:  2012-05-26       Impact factor: 3.686

3.  Gallium nitrate is efficacious in murine models of tuberculosis and inhibits key bacterial Fe-dependent enzymes.

Authors:  Oyebode Olakanmi; Banurekha Kesavalu; Rajamouli Pasula; Maher Y Abdalla; Larry S Schlesinger; Bradley E Britigan
Journal:  Antimicrob Agents Chemother       Date:  2013-09-23       Impact factor: 5.191

4.  Digalloylresveratrol, a novel resveratrol analog inhibits the growth of human pancreatic cancer cells.

Authors:  Philipp Saiko; Geraldine Graser; Benedikt Giessrigl; Marie-Thérèse Steinmann; Heike Schuster; Andreas Lackner; Michael Grusch; Georg Krupitza; Walter Jaeger; Venkateswarlu Somepalli; Trimurtulu Golakoti; Monika Fritzer-Szekeres; Thomas Szekeres
Journal:  Invest New Drugs       Date:  2013-08-14       Impact factor: 3.850

5.  The human equilibrative nucleoside transporter 1 mediates in vitro cytarabine sensitivity in childhood acute myeloid leukaemia.

Authors:  I Hubeek; R W Stam; G J Peters; R Broekhuizen; J P P Meijerink; E R van Wering; B E S Gibson; U Creutzig; C M Zwaan; J Cloos; D J Kuik; R Pieters; G J L Kaspers
Journal:  Br J Cancer       Date:  2005-12-12       Impact factor: 7.640

Review 6.  [Advances of drug resistance marker of gemcitabine for non-small cell lung cancer].

Authors:  Ying Chen; Xiaoping Qian; Baorui Liu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2011-05

7.  Identification of Monobenzone as a Novel Potential Anti-Acute Myeloid Leukaemia Agent That Inhibits RNR and Suppresses Tumour Growth in Mouse Xenograft Model.

Authors:  Jingwen Dong; Tingting Zhong; Zhijian Xu; Haiyi Chen; Xianjun Wang; Lili Yang; Zhiyuan Lou; Yuanling Xu; Tingjun Hou; Rongzhen Xu; Weiliang Zhu; Jimin Shao
Journal:  Cancers (Basel)       Date:  2022-09-27       Impact factor: 6.575

8.  Gemcitabine and carboplatin demonstrate synergistic cytotoxicity in cervical cancer cells by inhibiting DNA synthesis and increasing cell apoptosis.

Authors:  Guixiu Jin; Jing Zhao; Hongyan Qi; Meng Lou; Xia Liu; Yu Qu; Lingjun Zhao; Weifeng Zhang; Jimin Shao; Huizhen Zhong
Journal:  Onco Targets Ther       Date:  2013-11-25       Impact factor: 4.147

Review 9.  [Clinical significance of ERCC1, RRM1 and TS in non-small cell lung cancer].

Authors:  Pei Li; Xiaozheng Kang; Keneng Chen
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2014-06-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.